Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

March 01, 2016; Volume 13,Issue 1

Editorial

  • You have access
    The next generation of cancer management
    Wayne W. Grody
    Cancer Biology & Medicine March 2016, 13 (1) 1-2; DOI: https://doi.org/10.28092/j.issn.2095-3941.2016.0027

Review

  • You have access
    Current practices and guidelines for clinical next-generation sequencing oncology testing
    Samuel P. Strom
    Cancer Biology & Medicine March 2016, 13 (1) 3-11; DOI: https://doi.org/10.28092/j.issn.2095-3941.2016.0004
  • You have access
    Changing paradigm of cancer therapy: precision medicine by next-generation sequencing
    Yuan Xue and William R. Wilcox
    Cancer Biology & Medicine March 2016, 13 (1) 12-18; DOI: https://doi.org/10.28092/j.issn.2095-3941.2016.0003
  • You have access
    The potential for liquid biopsies in the precision medical treatment of breast cancer
    Victoria A. Forte, Dany K. Barrak, Mostafa Elhodaky, Lily Tung, Anson Snow and Julie E. Lang
    Cancer Biology & Medicine March 2016, 13 (1) 19-40; DOI: https://doi.org/10.28092/j.issn.2095-3941.2016.0007
  • You have access
    Acute myeloid leukemia in the era of precision medicine: recent advances in diagnostic classification and risk stratification
    Rina Kansal
    Cancer Biology & Medicine March 2016, 13 (1) 41-54; DOI: https://doi.org/10.28092/j.issn.2095-3941.2016.0001
  • You have access
    Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing
    Christine Stanislaw, Yuan Xue and William R. Wilcox
    Cancer Biology & Medicine March 2016, 13 (1) 55-67; DOI: https://doi.org/10.28092/j.issn.2095-3941.2016.0002
  • You have access
    Alterations in genes other than EGFR/ALK/ROS1 in non-small cell lung cancer: trials and treatment options
    Arpita Desai, Smitha P. Menon and Grace K. Dy
    Cancer Biology & Medicine March 2016, 13 (1) 77-86; DOI: https://doi.org/10.28092/j.issn.2095-3941.2016.0008
  • You have access
    Changing the paradigm: the potential for targeted therapy in laryngeal squamous cell carcinoma
    Megan L. Ludwig, Andrew C. Birkeland, Rebecca Hoesli, Paul Swiecicki, Matthew E. Spector and J. Chad Brenner
    Cancer Biology & Medicine March 2016, 13 (1) 87-100; DOI: https://doi.org/10.28092/j.issn.2095-3941.2016.0010
  • You have access
    Evolving role of adiponectin in cancer-controversies and update
    Arnav Katira and Peng H. Tan
    Cancer Biology & Medicine March 2016, 13 (1) 101-119; DOI: https://doi.org/10.28092/j.issn.2095-3941.2015.0092
  • You have access
    Colorectal cancer carcinogenesis: a review of mechanisms
    Kanwal Tariq and Kulsoom Ghias
    Cancer Biology & Medicine March 2016, 13 (1) 120-135; DOI: https://doi.org/10.28092/j.issn.2095-3941.2015.0103

Original Article

  • You have access
    Establishment and application of a multiplex genetic mutation-detection method of lung cancer based on MassARRAY platform
    Hong-Xia Tian, Xu-Chao Zhang, Zhen Wang, Jian-Guang Chen, Shi-Liang Chen, Wei-Bang Guo and Yi-Long Wu
    Cancer Biology & Medicine March 2016, 13 (1) 68-76; DOI: https://doi.org/10.28092/j.issn.2095-3941.2015.0094
  • You have access
    Second-line panitumumab as a triweekly dose for patients with wild-type KRAS exon 2 metastatic colorectal cancer: a single-institution experience
    Mohamed A. Daoud, Engy M. Aboelnaga and Wael M. Mohamed
    Cancer Biology & Medicine March 2016, 13 (1) 136-141; DOI: https://doi.org/10.28092/j.issn.2095-3941.2015.0009
  • You have access
    Is adjuvant chemotherapy necessary for patients with microinvasive breast cancer after surgery?
    Hai-Fei Niu, Li-Juan Wei, Jin-Pu Yu, Zhen Lian, Jing Zhao, Zi-Zheng Wu and Jun-Tian Liu
    Cancer Biology & Medicine March 2016, 13 (1) 142-149; DOI: https://doi.org/10.7497/j.issn.2095-3941.2015.0093

Meeting Report

  • You have access
    Advances in caring for the older cancer patient: a report from the 2015 conference of the International Society of Geriatric Oncology
    Rob Stepney
    Cancer Biology & Medicine March 2016, 13 (1) 150-155; DOI: https://doi.org/10.28092/j.issn.2095-3941.2016.0005
Back to top
PreviousNext

In this issue

Cancer Biology and Medicine: 13 (1)
Cancer Biology & Medicine
Vol. 13, Issue 1
1 Mar 2016
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

Jump to

  • Editorial
  • Review
  • Original Article
  • Meeting Report

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire